Phospho Soda Where To Buy
CLICK HERE ->->->-> https://urluso.com/2tk8PH
Phospho soda was an over the counter saline laxative produced by the C.B. Fleet Company in Lynchburg, Va. Phospho soda consisted mostly of monobasic sodium phosphate monohydrate and dibasic sodium phosphate heptahydrate. Phospho soda is often taken in a double dose (the usual 45ml dose, followed by a second 45ml dose 6 hours later), to prepare for colonoscopy. It is still used outside the US.
An amount of Phospho soda (normally 1.5 fluid ounce or 45 ml) is usually mixed with water or other clear liquids such as ginger ale. This preparation usually results in a bowel movement anywhere from 30 minutes to 6 hours after it is taken. Phospho soda is also available in various flavors to make it more palatable.[1]
The use of Phospho soda has been known to lead to acute phosphate nephropathy. According to the U.S. Food and Drug Administration (FDA), \"Acute phosphate nephropathy is a form of acute kidney injury that is associated with deposits of calcium-phosphate crystals in the renal tubules that may result in permanent renal function impairment. Acute phosphate nephropathy is a rare, serious adverse event that has been associated with the use of OSPs [oral sodium phosphates]. The occurrence of these events was previously described in an Information for Healthcare Professionals sheet and an FDA Science Paper issued in May 2006. Additional cases of acute phosphate nephropathy have been reported to FDA and described in the literature since these were issued.\"[2]
On December 11, 2008, the FDA issued a Safety Alert stating that \"FDA has become aware of reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products (OSP) for bowel cleansing prior to colonoscopy or other procedures. These products include the prescription products, Visicol and OsmoPrep, and OSPs available over-the-counter without a prescription as laxatives (e.g., Fleet Phospho-soda). In some cases when used for bowel cleansing, these serious adverse events have occurred in patients without identifiable factors that would put them at risk for developing acute kidney injury ... The agency is equally concerned about the risks associated with the use of OSP products that are available over-the-counter (OTC), for example, Fleet Phospho-soda, when used at higher doses for bowel cleansing.\"[2]
Phospho soda works by drawing liquid from the body into the colon, therefore it can cause severe dehydration, especially if not used properly. Usage in this context is highly recommended to be performed only with a doctor's knowledge and consent.
When Phospho soda is used as preparation for colonoscopy, 1.5 fluid ounces (45ml), mixed with an equal amount of water or any clear liquid and followed by 8 oz of water, is taken, followed by a second dose 6 hours later (3 oz total). It will cause very loose, eventually watery stools, usually starting within an hour or so and lasting several hours.
A 2007 study showed that in patients with decreased renal function, Phospho soda may worsen renal impairment compared to polyethylene glycol-based laxatives. In patients without kidney problems, no difference was observed.[4]
In December 2008, CB Fleet Company, Inc. recalled their colonoscopy prep Fleet Phosphosoda after the FDA indicated it should not be available over-the-counter. For years Fleet promoted their laxative for use at high doses as a bowel prep without adequate warnings about the potential risk for kidney damage. If proper warnings had been provided, many people may have avoided potentially life-threatening health problems by choosing one of the available Fleet Phospho Soda alternatives.
The Fleet recall was issued for Fleet Phospho-soda and Fleet Phospho-soda EZ Prep due to a potential risk that the high doses necessary for bowel cleansing may lead to acute phosphate nephropathy, a severe form of kidney damage that could cause renal failure, dialysis treatment or death.
Fleet Phosphasoda contains oral sodium phosphate, which was only approved for over-the-counter use as a laxative. However, about 15 years ago Fleet began marketing the use of double doses to cleanse the bowels before a colonoscopy or other surgical procedure.
However, there are several Fleet Phospho-soda alternatives that are already available that do not contain oral sodium phosphate and do not appear to carry the same risk of kidney damage. These include PEG solutions such as Golytely, Halflytely and Moviprep.
The Fleet Phosphosoda lawyers at Saiontz & Kirk, P.A. are investigating potential lawsuits on behalf of individuals who have been diagnosed with acute phosphate nephropathy or kidney damage after using a double dose of the oral sodium phosphate solution to cleanse their bowels before surgery or a colonoscopy.
CB Fleet has been aware of the potential risk of kidney damage for a number of years, yet they continued to market use of the product at high doses and failed to warn about the risk. If individuals had been warned about the risk of acute phosphate nephropathy, many may have chosen alternatives to Fleet Phospho-soda and avoided these problems.
Different out-come, but worth noting. I prepared for a colonoscopy using Golytely on 6/29/09. That evening I suffered a heart attack and was totally unconscious and on life support for 3 days. They brought me back from death 4 times. No where on the label does it state that someone my age (63) could possibly have serious repercussions to this medicine if they have an unknown problem, such as a heart vessel that is 75% blocked.
These guys are idiots, they think they are so smart and work for FDA, some even physicians and they didnt know that all they had to do was to tell the users of phosphosoda to drink 1/2 to 1 full gallon of water after drinking the phosphosoda to maintain sufficient liquid and hydration for the kidneys and prevent the renal failure its COMMON SENSE and im not even a physician. Come on guys it has sodium and retains water/absorbs water from your body so obviously hydration is important with these products. I have used phosphosoda for 3 years every 6 months and never ever had an issue. Please bring it back to the market.
This section provides information on the proper use of a number of products that contain sodium phosphate dibasic and sodium phosphate monobasic. It may not be specific to Fleet Phospho-soda EZ-Prep. Please read with care.
Take each dose (4 tablets) with 8 ounces of clear liquids. Examples of clear liquids include: water, flavored water, clear broth, herbal tea, black tea, coffee, clear soda, gelatin, popsicles, lemonade (no pulp), ginger ale, white grape juice, or apple juice. Do not eat or drink alcohol, milk, anything colored purple or red, or any foods that have pulp.
Fleet Phospho-soda is an over-the-counter oral sodium phosphate product that has been used as a laxative for many years. However, the products manufacturer also indicated that a double dosage of the product could be used as a bowel cleanser during colonoscopy prep. The FDA has never approved a double dosage of Fleet Phospho-soda for use in colonoscopy prep.
If you have developed acute phosphate nephropathy from using a Fleet Phospho-soda product prior to your colonoscopy, you may be eligible to receive compensation for your injuries. The Cochran Firm is a high-powered, nationwide law firm that has the vast resources and experience needed to help you achieve a successful outcome for your claim.
Phospho-soda has been rarely associated with severe and potentially fatal cases of electrolyte disorders in elderly patients. The benefit/risk ratio of Phospho-soda needs to be carefully considered before initiating treatment in this at-risk population.
Special attention should be taken when prescribing Phospho-soda to any patient with regard to known contraindications and the importance of adequate hydration and, in at-risk populations (see below and sections 4.2 and 4.3.), the importance of also obtaining baseline and post-treatment electrolyte levels.
This product usually works within to 6 hours. If there has been no bowel movement within 6 hours of taking Phospho-soda, instruct the patient to stop use and contact a doctor immediately as dehydration could occur.
Care should be taken to prescribe Phospho-soda per recommendations with a particular attention to known contraindications, adequate hydration prior to, during the preparation and after the procedure and adherence to recommended spacing of doses.
During the intake of Phospho-soda the absorption of drugs from the gastrointestinal tract may be delayed or even completely prevented. The efficacy of regularly taken oral drugs (e.g. oral contraceptives, antiepileptic drugs, antidiabetics, antibiotics) may be reduced or completely absent. Caution is also advised when taking medicines known to prolong the QT interval.
For Phospho-soda, no clinical data on exposed pregnancies and no data from animal studies with respect to effects on pregnancy, embryonal/fetal development, parturition and postnatal development are available. The potential risk for humans is unknown. Phospho-soda should not be used during pregnancy unless clearly necessary.
It is not known whether Phospho-soda is excreted in human milk. As sodium phosphate may pass into the breast milk, it is advised that breast milk is expressed and discarded from the first dose to 24 hours after the second dose of the bowel cleansing solution. Women should not breast-feed their infants until 24 hours after receiving the second dose of Phospho-soda.
There have been fatal cases of hyperphosphataemia with concomitant hypocalcaemia, hypernatraemia and acidosis when Phospho-soda has been used in excessive doses, given to children or to obstructed patients.
Phospho-soda is a saline laxative that acts by osmotic processes to increase fluid retention in the lumen of the small intestine. Fluid accumulation in the ileum produces distension and, in turn, promotes peristalsis and bowel evacuation.
Each 5mL of Fleet Phospho-soda contains sodium phosphate monobasic 2.4g and sodium phosphate dibasic 0.9g. DESCRIPTION: Fleet Phospho-soda is a stable, clear, colourless, buffered, ginger-lemon flavoured, aqueous solution 59ce067264